Clinical Trials
40 trialsRadiation Therapy With Protons or Photons in Treating Patients With Liver Cancer
NRG Oncology
Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer
Shandong Cancer Hospital and Institute
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
M.D. Anderson Cancer Center
SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute
Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response
Centre Oscar Lambret
Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular Carcinoma
Hebei Medical University Fourth Hospital
PRISM
Weill Medical College of Cornell University
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
University of California, San Francisco
SBRT + Atezolizumab + Bevacizumab in Resectable HCC
Massachusetts General Hospital
Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase II Study of Concurrent Lenvatinib and Radiotherapy for Advanced HCC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC
Shandong Cancer Hospital and Institute
SAVIOR
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy
Shanghai Zhongshan Hospital
SBRTvsTACE
Lahey Clinic
LiverMultiScan Analysis of MRI Scans in HCC
National Cancer Centre, Singapore
SBRTvsTACE
Lahey Clinic
Sintilimab and Bevacizumab Combined With Radiotherapy for Advanced Hepatocellular Carcinoma
Sun Yat-sen University
Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT
Beijing Tsinghua Chang Gung Hospital
ARTC-HCC
Guangxi Medical University
Radiofrequency Ablation Plus Radiotherapy for Small Hepatocellular Carcinoma
Guangxi Medical University
Perioperative Therapy for Hepatocellular Carcinoma
Zhejiang University
Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular Carcinoma
National Cancer Center, Korea
Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis
Beijing Tsinghua Chang Gung Hospital
Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC)
Guangxi Medical University
Hypofractionated Proton Beam Radiotherapy for Hepatocellular Carcinoma
National Cancer Center, Korea
Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases
UNC Lineberger Comprehensive Cancer Center
The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus
Guangxi Medical University
A Study of Individualized Radiotherapy Based on a Prediction Model of Lymph Node Metastasis in Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
Clinical Study of Effectiveness of Radiotherapy Before Surgery in High-risk Relapse Hepatocellular Cancer Patients
Peking Union Medical College
RTANDTACE
Asan Medical Center
Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma
Medical College of Wisconsin
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
National Cancer Institute (NCI)
Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery
Vanderbilt-Ingram Cancer Center
Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma
China Medical University Hospital
Combined Radiotherapy and Sorafenib in Patients With Hepatoma
China Medical University Hospital
A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC)
National Taiwan University Hospital
A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC)
National Taiwan University Hospital